论文部分内容阅读
目的探讨缩宫素在足月妊娠引产中的临床效果。方法将2007年3月—2011年1月收治的90例初产妇应用缩宫素进行晚期妊娠引产,观察其临床疗效。结果本研究结果显示宫颈评分的高低与引产成功率成正比,用药12h后宫颈成熟度为(8.72±2.31)分,其中有效77例(85.6%),用药至临床时间为10.6h,发生新生儿窒息4例(4.44%),表明缩宫素静脉滴注引产并不增加新生儿窒息的发生。结论缩宫素是一种安全有效、方便的促宫颈成熟和计划引产药物,且对新生儿无明显不良反应。
Objective To investigate the clinical effect of oxytocin in term labor induced labor. Methods From March 2007 to January 2011, 90 primipara patients treated with oxytocin were treated with late pregnancy induction of labor and the clinical efficacy was observed. Results The results of this study showed that the cervical score was proportional to the success rate of induced abortion. After 12 hours of treatment, the cervical maturity was (8.72 ± 2.31) points, of which 77 (85.6%) were effective and the clinical duration was 10.6 hours Asphyxiation in 4 cases (4.44%), indicating that oxytocin intravenous infusion does not increase the incidence of neonatal asphyxia. Conclusion oxytocin is a safe, effective and convenient cervical ripening and induced abortion drugs, and no obvious adverse reactions to the newborn.